All professional landings

Ketamine Therapy for Nurses  ·  Reviewed by Dr. Ben Soffer, DO

Built for the nurses schedule

Telehealth ketamine therapy designed around the privacy concerns, schedule pressures, and clinical patterns specific to registered nurses, nurse practitioners, and clinical nursing staff.

TL;DR

  • Nurses have elevated suicide and depression rates compared to the general population — recent epidemiological analyses (Kreuze 2025) identify nurses as a high-risk occupational group, with female nurses showing suicide rates substantially above age-matched non-nurses.
  • 12-hour shifts, secondary trauma exposure, moral injury from staffing shortages, and the COVID-era legacy of patient deaths produce a chronic-stress profile that's often not fully resolved by time off or therapy alone.
  • Telehealth ketamine therapy fits nursing schedules — sessions between shifts, no clinic visits, completely private from hospital systems and nurse-licensure databases.
  • Tovani is direct-pay ($349/month, HSA/FSA eligible) — bypasses hospital benefits records. For licensure and DEA-registration concerns, see privacy section below.
  • For treatment-resistant depression where multiple SSRIs and therapy haven't produced enough response, ketamine's NMDA/glutamate mechanism is a meaningfully different approach with rapid onset.
  • Most nurse-patients say what mattered most was: another clinician understanding shift work and trauma exposure; same physician every visit; clear answer on board and DEA implications; complete separation from hospital records.

Nurses carry a mental-health burden the public rarely sees behind the competence, and recent epidemiological work identifies them as a high-risk occupational group, with female nurses showing suicide rates substantially above age-matched non-nurses. The texture of the job explains much of it. Twelve-hour shifts shred sleep and recovery, while secondary trauma accumulates from sustained exposure to patient death. There is a specific wound called moral injury, knowing what good care looks like and being unable to deliver it because the unit is short-staffed, and the COVID era left many nurses carrying mass-casualty events never really processed.

Getting care is complicated for nurses in ways past the schedule. There is real and often exaggerated anxiety about board disclosure and, for the many APRNs holding DEA registration, about whether treatment might touch that registration. In truth, most state boards require disclosure only of conditions that impair fitness to practice, not the existence of treatment, but the fear alone suppresses help-seeking. The hospital setting compounds it, since a local clinic or employer EAP raises the risk of being seen by a coworker.

Telehealth ketamine therapy fits nursing schedules and answers the questions nurses actually ask. Sessions schedule on days off rather than before a shift, in your own home, completely private from coworkers, with the same physician every visit despite rotating schedules. Tovani is direct-pay, so there is no claim visible to your employer and nothing shared with a hospital, board, or the DEA without your authorization. Routine outpatient treatment that does not involve impaired practice is generally not a DEA-reportable event. Ketamine's mechanism differs from any SSRI, and the neuroplasticity window may aid trauma-focused therapy, though response varies.

The stressors specific to your work

  • Secondary trauma from sustained patient-death and crisis exposure
  • 12-hour shifts disrupting sleep, exercise, and recovery time
  • Moral injury from staffing shortages — knowing what good care looks like but unable to deliver it
  • Workplace violence (verbal and physical) directed at nursing staff at elevated rates
  • COVID-era legacy of repeated mass-casualty events still unprocessed for many
  • Board-disclosure and DEA-registration anxiety suppressing help-seeking

Why telehealth works for nurses

  • No clinic visits — fits between shifts and post-night rotations
  • Sessions scheduled on days off, no need to take PTO
  • Treatment in your own home — completely private from coworkers and management
  • Same physician every visit — continuity matters when shift schedules disrupt routine
  • Completely separate from hospital EAP, employer health plan, or licensing-board databases

Privacy considerations

  • Tovani is direct-pay — no insurance claim is filed unless you submit for reimbursement yourself.
  • Patient records are HIPAA-protected and never shared with hospitals, state boards of nursing, DEA, or any employer or regulatory body without your explicit written authorization.
  • State nursing board disclosure rules vary, but most jurisdictions only require disclosure of conditions that impair fitness to practice, not the existence of outpatient treatment itself. Routine, well-managed depression or anxiety treatment is generally not reportable.
  • For nurses with DEA registration (most APRNs and some specialty RNs), routine outpatient mental-health treatment that does not involve impaired-practice or controlled-substance misuse is generally not a DEA-reportable event — but if you have specific concerns, consult a nurse-attorney or your state's peer-assistance program (most states have confidential nurse-assistance programs separate from disciplinary processes).

DEA / licensure-sensitive role

Your profession has specific board-disclosure considerations. Discuss with your physician during consultation. For state-specific guidance, contact your state’s professional-assistance program.

Check eligibility for ketamine therapy

5-minute screening · Reviewed by a board-certified physician · FL & NJ · $349/month

Frequently asked

Will my state board of nursing find out?

No — not from Tovani. We don't report routine outpatient mental-health treatment to any state board or licensing database. Most state nursing-board disclosure questions ask about conditions that impair fitness to practice, NOT about whether you've ever received mental-health treatment. Well-managed outpatient depression or anxiety treatment is typically not reportable. If you have specific concerns, your state's confidential nurse-assistance program is a non-disciplinary resource — call them before disclosing anything to the board itself.

I have DEA registration as an APRN. Does ketamine treatment affect that?

Routine outpatient mental-health treatment that doesn't involve impaired-practice events or controlled-substance misuse is not a DEA-reportable event for registered prescribers. The DEA cares about your ability to securely handle controlled substances and prescribe responsibly — receiving treatment for depression doesn't affect either. If you have specific concerns or there's a complicating factor (past DEA action, hospital credentialing issue), consult a healthcare attorney before starting.

I work night shifts. Can I do ketamine therapy while doing nights?

Yes, with planning. Sessions are scheduled on your days off, not before a shift. Avoid scheduling within 24 hours of a clinical shift. Many night-shift nurses do sessions on the first full day after a rotation block and before the next one begins. Your physician helps work it around your schedule.

I've tried SSRIs and therapy and the moral injury / burnout hasn't lifted. What now?

When standard approaches produce only partial response, options include mechanism-switching (NDRI, SNRI, ketamine), augmentation strategies, TMS, or — for the specific subset where the pattern is treatment-resistant depression with chronic occupational trauma — ketamine combined with trauma-focused therapy. The "neuroplasticity window" effect after ketamine sessions may enhance trauma-processing therapy work.

Can I do this without my manager / charge nurse / coworkers knowing?

Yes. Tovani is HIPAA-protected, direct-pay (no insurance claim visible to your employer), and never shares information with hospitals, healthcare systems, or coworkers without your explicit written authorization. Sessions happen in your home — no clinic where coworkers might see you. Many nurse-patients keep this entirely separate from their professional environment.

References

  1. Kreuze E et al. 2025, Journal of Nursing Scholarship. Global examination of nurse suicide epidemiology and cohort data — establishes elevated suicide risk and the need for treatment access models that account for licensure and stigma barriers. PMID 40110987
  2. Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT showed 64% response in treatment-resistant depression — relevant for high-prevalence professions like nursing where prior antidepressant trials are common. PMID 23982301
  3. Sanacora G et al. 2017, JAMA Psychiatry. APA consensus on ketamine's rapid antidepressant effects in clinical contexts requiring faster response than SSRIs typically provide. PMID 28249076

Other professional landings